Ixchiq Disease Interactions
There is 1 disease interaction with Ixchiq (chikungunya vaccine, live (cvx 317)).
Moderate
Vaccines (live attenuated/toxoid) (applies to Ixchiq) immunocompromised
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency
The expected antibody responses may not be obtained when live attenuated vaccines and/or toxoids are administered to immunosuppressed persons, including those receiving immunosuppressive therapy. Caution and close monitoring is advised.
Switch to professional interaction data
Ixchiq drug interactions
There are 341 drug interactions with Ixchiq (chikungunya vaccine, live (cvx 317)).
Report options
QR code containing a link to this page
More about Ixchiq (chikungunya vaccine, live (cvx 317))
- Ixchiq consumer information
- Check interactions
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
